|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.94 USD | -1.53% |
|
-0.41% | -9.14% |
| 07-13 | Stoke Therapeutics Announces Appointment of Thomas McCauley as Chief Scientific Officer | CI |
| 07-13 | Goldman Sachs Initiates Coverage on Stoke Therapeutics With Buy Rating, $44 Price Target | MT |
| Market Cap | 1.83B 1.61B 1.5B 1.38B 2.58B 175B 2.64B 17.8B 6.96B 86.76B 6.87B 6.72B 300B | P/E 2026 * |
-8.95x | P/E 2027 * | -9.28x |
|---|---|---|---|---|---|
| Enterprise Value | 1.64B 1.44B 1.34B 1.23B 2.31B 157B 2.36B 15.91B 6.22B 77.55B 6.14B 6.01B 268B | EV / Sales 2026 * |
67.3x | EV / Sales 2027 * | 33.9x |
| Free-Float |
96.18% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Stoke Therapeutics, Inc.
| 1 day | -1.19% | ||
| 1 week | -0.41% | ||
| Current month | -11.86% | ||
| 1 month | -10.96% | ||
| 3 months | -11.04% | ||
| 6 months | -7.18% | ||
| Current year | -9.14% |
| 1 week | 28.33 |  | 30.92 |
| 1 month | 27.24 | | 33.72 |
| Current year | 25.21 | | 40.22 |
| 1 year | 12.4 | | 40.22 |
| 3 years | 3.35 | | 40.22 |
| 5 years | 3.35 | | 40.22 |
| 10 years | 3.35 | | 71.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Isabel Aznarez
CTO | Chief Tech/Sci/R&D Officer | 54 | 2014-05-31 |
Ian Smith
CEO | Chief Executive Officer | 60 | 2025-03-18 |
Thomas Leggett
DFI | Director of Finance/CFO | 49 | 2024-05-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Harrison
CHM | Chairman | 65 | 2015-06-30 |
Adrian Krainer
BRD | Director/Board Member | 67 | 2014-05-31 |
Arthur Levin
BRD | Director/Board Member | 72 | 2015-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/16/26 | Don | Director | -303,190 | 0.5126% | ||
| 7/15/26 | Free | Chief Technology Officer | 225,000 | 0.3804% | ||
| 7/1/26 | Sell | Chief Technology Officer | -7,228 | 0.0122% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.53% | -0.41% | +130.72% | +334.34% | 1.83B | |
| +2.61% | +7.16% | -0.93% | +13.78% | 47.88B | |
| -1.29% | -1.70% | +386.15% | +585.43% | 39.09B | |
| -1.13% | +2.18% | +6.93% | +52.61% | 36.75B | |
| +0.36% | +23.43% | +25.95% | +9.51% | 40.55B | |
| +1.47% | +4.90% | +6.48% | +43.52% | 27.96B | |
| -0.41% | +0.29% | - | - | 16.77B | |
| +1.11% | +9.48% | +29.09% | +128.38% | 15.94B | |
| +0.18% | -2.75% | +3.22% | +9.68% | 13.55B | |
| -0.42% | +6.84% | -3.50% | -28.91% | 13.81B | |
| Average | +0.12% | +4.40% | +64.90% | +127.59% | 25.41B | |
| Weighted average by Cap. | +0.33% | +5.04% | +72.62% | +124.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 24.32M 21.37M 19.95M 18.3M 34.27M 2.33B 35.11M 237M 92.5M 1.15B 91.3M 89.32M 3.98B | 46.5M 40.86M 38.14M 35.01M 65.53M 4.45B 67.14M 452M 177M 2.2B 175M 171M 7.62B |
| Net income | -211M -185M -173M -159M -297M -20.18B -304M -2.05B -802M -9.99B -791M -774M -34.53B | -212M -186M -174M -160M -299M -20.32B -306M -2.06B -807M -10.05B -796M -779M -34.75B |
| Net Debt | -194M -171M -159M -146M -274M -18.62B -281M -1.89B -739M -9.21B -730M -714M -31.85B | -256M -225M -210M -193M -361M -24.54B -370M -2.49B -974M -12.14B -962M -941M -41.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-29 | US$29.06 | -1.12% | 143,464 |
| 26-07-28 | US$29.39 | +0.27% | 598,353 |
| 26-07-27 | US$29.31 | +0.03% | 594,611 |
| 26-07-24 | US$29.30 | -1.18% | 441,847 |
| 26-07-23 | US$29.65 | +2.38% | 669,437 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- STOK Stock
Select your edition
All financial news and data tailored to specific country editions
